Peficitinib, a JAK inhibitor, in the treatment of moderate-to-severe rheumatoid arthritis in methotrexate-inadequate responders
Kivitz, A. J., Gutierrez-Ureña, S. R., Poiley, J., Genovese, M. C., Kristy, R., Shay, K., Wang, X., Garg, J. P., Zubrzycka-Sienkiewicz, A.Language:
english
Journal:
Arthritis & Rheumatology
DOI:
10.1002/art.39955
Date:
October, 2016
File:
PDF, 1.29 MB
english, 2016